Search

everythinglearnresearchcommunity

for

Search:↓

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

The summit aimed to speed up finding treatments for alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

Trichotillomania is a chronic hair-pulling disorder that starts in early teens and causes distress and hair loss.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Polycystic Ovarian Syndrome (PCOS) can cause chronic inflammation, mental health issues, and changes in gut bacteria, but a holistic lifestyle change can significantly improve these conditions.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

People with depression often have higher hair cortisol levels, while those with PTSD tend to have lower levels, but more research is needed to understand this fully.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.